Stephens Inc. AR grew its position in Colgate-Palmolive (NYSE:CL – Free Report) by 21.4% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 14,506 shares of the company’s stock after purchasing an additional 2,555 shares during the period. Stephens Inc. AR’s holdings in Colgate-Palmolive were worth $1,319,000 as of its most recent SEC filing.
A number of other hedge funds also recently made changes to their positions in the business. FMR LLC boosted its stake in Colgate-Palmolive by 65.6% during the third quarter. FMR LLC now owns 6,749,275 shares of the company’s stock valued at $700,642,000 after buying an additional 2,674,807 shares in the last quarter. Barclays PLC grew its stake in shares of Colgate-Palmolive by 38.7% in the 3rd quarter. Barclays PLC now owns 7,644,189 shares of the company’s stock worth $793,542,000 after purchasing an additional 2,132,747 shares during the last quarter. State Street Corp raised its holdings in shares of Colgate-Palmolive by 3.8% in the 3rd quarter. State Street Corp now owns 48,436,276 shares of the company’s stock worth $5,028,170,000 after purchasing an additional 1,784,411 shares in the last quarter. Nordea Investment Management AB lifted its stake in Colgate-Palmolive by 32.5% during the fourth quarter. Nordea Investment Management AB now owns 5,091,683 shares of the company’s stock valued at $462,121,000 after purchasing an additional 1,247,731 shares during the last quarter. Finally, Jacobs Levy Equity Management Inc. grew its position in Colgate-Palmolive by 864.1% in the third quarter. Jacobs Levy Equity Management Inc. now owns 777,854 shares of the company’s stock worth $80,749,000 after buying an additional 697,168 shares during the last quarter. Institutional investors own 80.41% of the company’s stock.
Analyst Upgrades and Downgrades
A number of brokerages recently issued reports on CL. Stifel Nicolaus decreased their target price on Colgate-Palmolive from $95.00 to $93.00 and set a “hold” rating on the stock in a report on Monday, February 3rd. Barclays cut their price objective on Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating on the stock in a report on Friday, January 17th. Piper Sandler decreased their target price on shares of Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating for the company in a report on Monday, January 6th. Morgan Stanley reduced their price target on shares of Colgate-Palmolive from $111.00 to $104.00 and set an “overweight” rating for the company in a research report on Monday, February 3rd. Finally, Wells Fargo & Company reduced their target price on Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating for the company in a report on Tuesday, January 7th. One research analyst has rated the stock with a sell rating, ten have given a hold rating and twelve have given a buy rating to the company’s stock. Based on data from MarketBeat.com, Colgate-Palmolive currently has an average rating of “Hold” and a consensus target price of $101.16.
Colgate-Palmolive Price Performance
Colgate-Palmolive stock opened at $86.75 on Thursday. The business’s fifty day moving average is $90.00 and its two-hundred day moving average is $96.61. The company has a debt-to-equity ratio of 9.46, a quick ratio of 0.26 and a current ratio of 0.41. The firm has a market cap of $70.88 billion, a P/E ratio of 24.64, a P/E/G ratio of 4.12 and a beta of 0.44. Colgate-Palmolive has a 52 week low of $82.76 and a 52 week high of $109.30.
Colgate-Palmolive (NYSE:CL – Get Free Report) last issued its quarterly earnings data on Friday, January 31st. The company reported $0.91 EPS for the quarter, topping analysts’ consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same quarter last year, the company posted $0.87 EPS. Equities research analysts forecast that Colgate-Palmolive will post 3.73 earnings per share for the current fiscal year.
Colgate-Palmolive Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Tuesday, January 21st will be issued a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a yield of 2.31%. The ex-dividend date of this dividend is Tuesday, January 21st. Colgate-Palmolive’s dividend payout ratio is 56.82%.
Colgate-Palmolive Profile
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
See Also
- Five stocks we like better than Colgate-Palmolive
- What is Short Interest? How to Use It
- 3 Reasons Micron Stock Is Deeply Undervalued Right Now
- How to Invest in the FAANG Stocks
- Inflation Persists, But So Do Stock Opportunities: Rally On
- 3 Grocery Stocks That Are Proving They Are Still Essential
- Energy Transfer Fuels the Cloud: A Natural Gas Power Play
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.